Internal Medicine, Interventional Cardiology · Edison, NJ
NPI
1871543389
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
225 May St, Suite F
Edison, NJ, 08837
Phone (732) 738-8855
Groups this clinician bills Medicare through
Medicare paid, 2024
$371K
5,330 services
Medicare patients, 2024
1,252
Average age 77
Drug cost, 2024
$2.0M
10,021 prescriptions
Company payments, 2025
$2,797
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Howard D Noveck was code 99214 (office e&m - established), 1,214 times for 463 patients. In total Howard D Noveck billed 5,330 services in 80 codes, and Medicare paid $371K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,214 | 463 | $99.19 | $120K |
| 99232 Hospital E&M - Subsequent | Facility | 1,160 | 280 | $66.18 | $77K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 609 | 339 | $13.19 | $8,034 |
| 93000 Electrocardiogram | Office | 443 | 317 | $11.45 | $5,074 |
| 78452 Myocardial Perfusion Scan | Office | 288 | 287 | $99.30 | $29K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 206 | 53 | $5.92 | $1,220 |
| 93306 Echocardiography (TTE/TEE) | Facility | 146 | 146 | $51.80 | $7,563 |
| 99222 Hospital E&M - Initial | Facility | 125 | 112 | $110.17 | $14K |
| 99213 Office E&M - Established | Office | 100 | 79 | $67.86 | $6,786 |
| 93288 External Electrocardiographic Monitoring | Office | 88 | 33 | $44.54 | $3,919 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 78 | 76 | $123.31 | $9,619 |
| 99233 Hospital E&M - Subsequent | Facility | 71 | 34 | $99.17 | $7,041 |
| 93015 Electrocardiogram | Office | 60 | 60 | $57.66 | $3,460 |
| 99204 Office E&M - New | Office | 58 | 58 | $131.89 | $7,649 |
| 85610 Clinical Chemistry | Office | 50 | 13 | $4.20 | $210 |
By year: 2022 $316K for 3,938 services; 2023 $377K for 4,731 services; 2024 $371K for 5,330 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 50 | 13 | $4.20 | $210 |
Medicare prescription drug claims, 2024
In 2024, the drug Howard D Noveck prescribed most often to Medicare patients was Metoprolol Succinate, with 691 prescriptions and refills. In total Howard D Noveck wrote 10,021 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 691 | 1,889 | 203 | $11K |
| Atorvastatin Calcium Generic | 606 | 1,681 | 171 | $6,878 |
| Rosuvastatin Calcium Generic | 522 | 1,461 | 164 | $6,612 |
| Amlodipine Besylate Generic | 494 | 1,421 | 172 | $3,852 |
| Clopidogrel Clopidogrel Bisulfate | 322 | 944 | 108 | $5,379 |
| Furosemide Generic | 298 | 746 | 104 | $1,203 |
| Lisinopril Generic | 273 | 806 | 88 | $2,041 |
| Eliquis Apixaban | 263 | 500 | 65 | $280K |
| Levothyroxine Sodium Generic | 214 | 586 | 64 | $2,639 |
| Entresto Sacubitril/Valsartan | 207 | 381 | 47 | $230K |
| Metoprolol Tartrate Generic | 202 | 580 | 69 | $1,428 |
| Spironolactone-Hctz Spironolact/Hydrochlorothiazid | 198 | 486 | 68 | $6,279 |
| Valsartan Generic | 189 | 542 | 71 | $5,918 |
| Ezetimibe Generic | 176 | 515 | 67 | $5,478 |
| Jardiance Empagliflozin | 169 | 358 | 40 | $206K |
Brand drugs: 1,689 claims; generic drugs: 8,319 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Howard D Noveck $2,797 ($2,797 in general payments such as food, travel and fees) from 21 companies. The largest payer was CVRx, Inc. with $1,050.
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. CVRX | 10 | $1,050 |
| Boston Scientific Corporation BSX | 12 | $568 |
| Heartflow, Inc. HTFL | 7 | $265 |
| Novartis Pharmaceuticals Corporation NVS | 27 | $154 |
| Amgen Inc. AMGN | 9 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $97.28 |
| BridgeBio Pharma, Inc. BBIO | 5 | $85.33 |
| Novo Nordisk Inc NVO | 4 | $70.39 |
| Merck Sharp & Dohme LLC MRK | 3 | $56.76 |
| Abiomed JNJ | 2 | $53.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.